ScholarIQanswers from OpenAlex

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

PaperCitations, authors & open-access status

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials is a paper indexed in ScholarIQ from OpenAlex.

How many citations does SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials have?

ScholarIQcitation count

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials has 952 citations in the OpenAlex counts ScholarIQ stores.

When was SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials published?

ScholarIQyear

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials has 2022 year in the ScholarIQ index.

What is the open-access status of SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials?

ScholarIQoa status

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials has hybrid oa status in the ScholarIQ index.

What is the DOI of SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials?

ScholarIQdoi

The DOI for SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials is on the source record.

What is the PMID of SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials?

ScholarIQpmid

The PMID for SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials is on the source record.

What is the OpenAlex record for SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials?

ScholarIQopenalex

The OpenAlex for SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial